Skandinaviska Enskilda Banken (STO:SEB-A) Stock Crosses Below 200-Day Moving Average of $88.34

Share on StockTwits

Skandinaviska Enskilda Banken AB (STO:SEB-A) passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $88.34 and traded as low as $81.50. Skandinaviska Enskilda Banken shares last traded at $82.10, with a volume of 4,513,962 shares.

The firm’s fifty day simple moving average is SEK 88.72 and its 200 day simple moving average is SEK 88.28.

Skandinaviska Enskilda Banken Company Profile (STO:SEB-A)

Skandinaviska Enskilda Banken AB (SEB) is a Sweden-based bank. The Bank’s operations are divided into four business segments. The Merchant Banking segment offers commercial and investment banking services to large corporate and institutional clients, mainly in the Nordic region and Germany. The Retail Banking segment offers banking and advisory services to private individuals and small and medium-sized corporate customers in Sweden, and card operations in the Nordic countries.

Recommended Story: Balanced Fund

Receive News & Ratings for Skandinaviska Enskilda Banken Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skandinaviska Enskilda Banken and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

QuickLogic  Downgraded by Zacks Investment Research to Sell
QuickLogic Downgraded by Zacks Investment Research to Sell
Regeneron Pharmaceuticals  Upgraded to “Buy” by BidaskClub
Regeneron Pharmaceuticals Upgraded to “Buy” by BidaskClub
Proofpoint  Raised to “Buy” at BidaskClub
Proofpoint Raised to “Buy” at BidaskClub
Omeros  Upgraded at BidaskClub
Omeros Upgraded at BidaskClub
360 Finance  Rating Increased to Buy at ValuEngine
360 Finance Rating Increased to Buy at ValuEngine
Kiniksa Pharmaceuticals  Downgraded by Zacks Investment Research to “Sell”
Kiniksa Pharmaceuticals Downgraded by Zacks Investment Research to “Sell”


 
© 2006-2020 Zolmax.